July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Diagnosis and treatment at the same time? With theranostics, it's possible
March 27, 2019 | Zen Vuong
A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” — therapy combined with diagnostics — that target specific tumors and diseases.
Study explores why glioblastoma affects sexes differently
February 25, 2019 | City of Hope
A nationwide team of researchers that includes City of Hope’s Translational Genomics Research Institute (TGen) has identified molecular differences that explain why men die of glioblastoma, a type of brain cancer, at nearly twice the rate of women.
Vanessa Jonsson, Ph.D.: An engineer tackles CAR T cell therapy
February 13, 2019 | City of Hope
Vanessa Jonsson, Ph.D., focuses on chimeric antigen receptor (CAR) T cell therapy. Using such tools as computational analysis and mathematical modeling, she examines the complex interactions between the tumor, the patient’s immune system and the therapy to learn how the tumor evades the immune response.
Clinical research nurses: ‘Shepherds’ of the CAR T program
January 9, 2019 | Abe Rosenberg
What's it like to work at the center of a true medical and scientific revolution? It's emotional, often overwhelming. But it’s also a place to witness miracles. Such is the life of the clinical research nurses who staff City of Hope's CAR T cell program.
Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain
October 30, 2018 | Letisia Marquez
A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants.
CIRM Awards City of Hope Researchers $3.7 million to Develop Glioblastoma Clinical Trial
September 28, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
A breakthrough treatment for melanoma metastasized to the brain
September 6, 2018 | Maxine Nunes
A remarkable new study, groundwork for which was begun by City of Hope oncologist Kim Margolin, M.D., brings new hope to people with melanoma that has metastasized to the brain.